J. Choi

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Jong Young Choi, Jong-young Choi, Jong Y Choi, Jonghwan Choi, Jong‐young Choi
Publication record
360 papers · 8,094 citations · H-index 47

PAPERS

Distinguishing True Immune Tolerant Hepatitis B Patients: Insights From Long‐Term Clinical Outcomes
20250 citationsauthor #9
Prediction of long-term HBsAg seroclearance in patients with HBeAg-negative chronic hepatitis B
20254 citationsauthor #13
Male preference for TERT alterations and HBV integration in young-age HBV-related HCC: implications for sex disparity
20254 citationsauthor #10
Differential HBV replicative markers and covalently closed circular DNA transcription in immune‐active chronic hepatitis B with and without HBeAg
20242 citationsauthor #10
Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study
20244 citationsauthor #6
Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study
20242 citationsauthor #18
Role of Portosystemic Shunt and Portal Vein Stent in Managing Portal Hypertension Due to Hematological Diseases
20240 citationsauthor #8
A Machine Learning Algorithm Facilitates Prognosis Prediction and Treatment Selection for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma.
202410 citationsauthor #19
Consistent efficacy of hepatic artery infusion chemotherapy irrespective of PD‑L1 positivity in unresectable hepatocellular carcinoma
20241 citationsauthor #8
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B
20242 citationsauthor #14
Expansion of effector regulatory T cells in steroid responders of severe alcohol-associated hepatitis
20241 citationsauthor #11
THU-530 Roles of intrahepatic IgA on the fibroblast activation in livers with steatotic liver diseases
20240 citationsauthor #5
Chitinase 1: a novel therapeutic target in metabolic dysfunction-associated steatohepatitis
20242 citationsauthor #8
Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of HCC
20247 citationsauthor #12
Efficacy comparison of high-genetic barrier nucleos(t)ide analogues in treatment-naïve chronic hepatitis B patients: a network meta-analysis
20241 citationsauthor #6
An Immunological Perspective on the Mechanism of Drug Induced Liver Injury: Focused on Drugs for Treatment of Hepatocellular Carcinoma and Liver Transplantation
202319 citationsauthor #2
An increase in the number of activated regulatory T cells is associated with an improvement in liver function of patients with severe alcoholic hepatitis after steroid therapy
20230 citationsauthor #6
Higher Number of Tumor-Infiltrating PD-L1+ Cells Is Related to Better Response to Multikinase Inhibitors in Hepatocellular Carcinoma
20233 citationsauthor #6
Intrahepatic infiltration of activated CD8+ T cells and mononuclear phagocyte is associated with idiosyncratic drug-induced liver injury
202313 citationsauthor #10
A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
20238 citationsauthor #21
Comparative Analysis of Atezolizumab Plus Bevacizumab and Hepatic Artery Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter, Propensity Score Study
20236 citationsauthor #8
Corrigendum: Intrahepatic infiltration of activated CD8+ T cells and mononuclear phagocyte is associated with idiosyncratic drug-induced liver injury
20233 citationsauthor #10
Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data
20236 citationsauthor #6
Analysis of Immune-Related Adverse Events of Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma: A Multicentre Cohort Study
202312 citationsauthor #15
Genotype–Phenotype Association in ABCC2 Exon 18 Missense Mutation Leading to Dubin–Johnson Syndrome: A Case Report
20222 citationsauthor #6
Long-term Clinical Outcomes and Predictive Factors for Living-donor Liver Transplant Recipients With Biliary Strictures
20228 citationsauthor #2
Intrahepatic inflammatory IgA+PD-L1high monocytes in hepatocellular carcinoma development and immunotherapy
202229 citationsauthor #11
Serum exosomal miRNA-720 as a diagnostic marker for hepatocellular carcinoma
20221 citationsauthor #9
A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
202240 citationsauthor #10
Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease
20223 citationsauthor #20
Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study
20223 citationsauthor #21
Multidisciplinary approach for hepatocellular carcinoma arising from cirrhotic liver with Budd-Chiari syndrome: a case report
20221 citationsauthor #5
Diagnostic performance of serum exosomal miRNA-720 in hepatocellular carcinoma
20226 citationsauthor #10
MiR-23b-3p suppresses epithelial-mesenchymal transition, migration, and invasion of hepatocellular carcinoma cells by targeting c-MET
20228 citationsauthor #5
Intrahepatic inflammatory IgA+PD-L1high monocytes in hepatocellular carcinoma development and immunotherapy
202229 citationsauthor #12
Sorafenib for advanced hepatocellular carcinoma provides better prognosis after liver transplantation than without liver transplantation
202115 citationsauthor #14
A Multivalent Vaccine Containing Actinobacillus pleuropneumoniae and Mycoplasma hyopneumoniae Antigens Elicits Strong Immune Responses and Promising Protection in Pigs
20213 citationsauthor #5
Use of M2BPGi in HCC patients with TACE
202111 citationsauthor #7
Reactivation of resolved hepatitis B after daratumumab for multiple myeloma.
202120 citationsauthor #7
Distinct Patterns of HBV Integration and TERT Alterations between in Tumor and Non-Tumor Tissue in Patients with Hepatocellular Carcinoma
202124 citationsauthor #8
Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
202128 citationsauthor #5
Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma
202133 citationsauthor #11
Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma
202137 citationsauthor #18
Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant
20218 citationsauthor #10
Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study
202121 citationsauthor #18
Anticancer Effect of Statins in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
202113 citationsauthor #5
Improving the prediction of relapse after nucleos(t)ide analogue discontinuation in patients with chronic hepatitis B.
20219 citationsauthor #7
Whole blood viscosity is associated with extrahepatic metastases and survival in patients with hepatocellular carcinoma
202113 citationsauthor #4
Effects of Positive Hepatitis B Core Antibody and Metabolic Disorders in Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus
20213 citationsauthor #8
Evaluating the Effect of Statins on Prognosis in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
20210 citationsauthor #5
Exosomal miR-125b Exerts Anti-Metastatic Properties and Predicts Early Metastasis of Hepatocellular Carcinoma
202133 citationsauthor #7
Prediction of Hepatocellular Carcinoma by On-Therapy Response of Noninvasive Fibrosis Markers in Chronic Hepatitis B
20217 citationsauthor #13
Acute‐on‐chronic liver failure due to infarction of multiple cirrhotic nodules
20210 citationsauthor #2
Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection
202029 citationsauthor #10
Serum Interleukin-33 Level Was Associated with Previous Acute Exacerbation History in Chronic Obstructive Pulmonary Disease Patients
20201 citationsauthor #1
A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC
202036 citationsauthor #15
Effectiveness of Sorafenib Dose Modifications on Treatment Outcome of Hepatocellular Carcinoma: Analysis in Real-Life Settings.
202017 citationsauthor #3
METFORMIN COMBINATION WITH TACROLIMUS ATTENUATE GVHD SEVERITY IN MICE BY MODULATING TREG AND TH17 IMBALANCE
20200 citationsauthor #2
Diffusion-Weighted Magnetic Resonance Imaging in Hepatocellular Carcinoma as a Predictor of a Response to Cisplatin-Based Hepatic Arterial Infusion Chemotherapy
202014 citationsauthor #7
EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
202099 citationsauthor #8
Effectiveness of sorafenib dose modifications on treatment outcome of hepatocellular carcinoma: analysis in real-life settings
20200 citationsauthor #4
Unexpected Improvement of Liver Function by Intravenous Immunoglobulin in a Steroid-Experienced Severe Alcoholic Hepatitis
20200 citationsauthor #5
Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance
202034 citationsauthor #8
Sustained off therapy response after peglyated interferon favours functional cure and no disease progression in chronic hepatitis B
202014 citationsauthor #11
Association of prophylactic anti-HBV therapy with improved long-term survival in patients with hepatocellular carcinoma undergoing transarterial therapy.
202017 citationsauthor #11
Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation
20201 citationsauthor #6
Infiltration of T Cells and Programmed Cell Death Ligand 1-expressing Macrophages as a Potential Predictor of Lenvatinib Response in Hepatocellular Carcinoma
20207 citationsauthor #7
Circulating exosomal microRNA-125b inhibits metastasis of hepatocellular carcinoma
20200 citationsauthor #7
Relative skeletal muscle mass and non-alcoholic fatty liver disease: from association to causation.
20192 citationsauthor #2
Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with my- eloproliferative neoplasms
20195 citationsauthor #10
FRI-477-Factors associated with good postprogression survival in post-sorafenib progressed advanced hepatocellular carcinoma pateitns not eligible for regorafenib
20190 citationsauthor #14
Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization
2019155 citationsauthor #8
A Model to Predict 1‐Month Risk of Transplant or Death in Hepatitis A–Related Acute Liver Failure
201927 citationsauthor #5
Presentation_1_Ex vivo Detection and Characterization of Hepatitis B Virus-Specific CD8+ T Cells in Patients Considered Immune Tolerant.pdf
20190 citationsauthor #10
FRI-177-Association of prophylactic anti-HBV therapy with improved long-term survival in patients with hepatocellular carcionoma undergoing transarterial therapy
20190 citationsauthor #9
Clinical outcomes after the introduction of direct antiviral agents for patients infected with genotype 1b hepatitis C virus depending on the regimens: A multicenter study in Korea
201911 citationsauthor #21
Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naïve Patients with Chronic Hepatitis B in Korea
201910 citationsauthor #5
Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis
2019117 citationsauthor #9
Impact of Enterococcal Bacteremia in Liver Transplant Recipients.
201918 citationsauthor #6
Reduction of Intrahepatic Tumour by Hepatic Arterial Infusion Chemotherapy Prolongs Survival in Hepatocellular Carcinoma
201923 citationsauthor #8
Control of intracranial disease is associated with improved survival in patients with brain metastasis from hepatocellular carcinoma
201912 citationsauthor #8
Circulating pro- and anti-angiogenic factors in multi-stage liver disease and hepatocellular carcinoma progression
201925 citationsauthor #8
FRI-187-Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and liver-related events in patients with chronic hepatitis B: A propensity score analysis
20192 citationsauthor #9
Liver Transplantation after Successful Downstaging with Hepatic Arterial Infusion Chemotherapy in a Patient with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
20190 citationsauthor #6
Ex vivo Detection and Characterization of Hepatitis B Virus-Specific CD8+ T Cells in Patients Considered Immune Tolerant
201918 citationsauthor #10
Invasive fungal infection in liver transplant recipients in a prophylactic era
201915 citationsauthor #3
Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B
201913 citationsauthor #6
A pilot comparative study of recombinant protein and whole-virus inactivated vaccines against porcine circovirus type 2 in conventionally reared pigs.
20193 citationsauthor #1
Pathologic complete response to chemoembolization improves survival outcomes after curative surgery for hepatocellular carcinoma: predictive factors of response.
201916 citationsauthor #9
18F–fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatment
201832 citationsauthor #7
Long-term outcome of donor biliary complications following living donor liver transplantation
20181 citationsauthor #5
Outcome of donor biliary complications following living donor liver transplantation
201817 citationsauthor #6
Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
201818 citationsauthor #7
Early-Onset and Late-Onset Bacteremias After Liver Transplantation
20181 citationsauthor #3
Clinical outcome of 1,000 consecutive cases of liver transplantation: a single center experience
201810 citationsauthor #7
Transarterial Chemolipiodolization for Hepatocellular Carcinoma with Central Bile Duct Invasion Causing Conjugated Hyperbilirubinemia: Safety and Prognostic Factors for Survival
20183 citationsauthor #7
Metformin ameliorates experimental-obesity-associated autoimmune arthritis by inducing FGF21 expression and brown adipocyte differentiation
201865 citationsauthor #8
Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them
20181 citationsauthor #11
Cucurbitacin E ameliorates acute graft-versus-host disease by modulating Th17 cell subsets and inhibiting STAT3 activation.
201810 citationsauthor #10
Effects of Virologic Response to Treatment on Short‐ and Long‐term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis
201862 citationsauthor #2

TIMELINE

1994 0 citations

1997 1 citations

1998 32 citations

2000 0 citations

2001 63 citations

2002 8 citations

2003 19 citations

2004 400 citations

2005 266 citations

2006 554 citations

2007 423 citations

2008 403 citations

2009 341 citations

2010 766 citations

2011 613 citations

2012 885 citations

2013 598 citations

2014 176 citations

2015 399 citations

2016 285 citations

2017 387 citations

2018 220 citations

2019 472 citations

2020 269 citations

2021 278 citations

2022 101 citations

2023 70 citations

2024 32 citations

2025 8 citations

Unknown 0 citations

J. Choi

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT